急性咽頭炎の世界市場レポート 2025年

急性咽頭炎市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.5％で39億8,000万米ドルに成長します。予測期間中に予測される成長は、インフルエンザや溶連菌感染症の流行増加、個別化医療の重視、迅速診断検査の採用率の上昇、ヘルスケアインフラの進歩、新興市場における医療アクセスの拡大などの要因に関連します。予測期間を形成すると予想される主な動向には、市販の治療薬へのシフト、併用療法の増加、咽頭炎の診断における遠隔医療の拡大、自然療法や代替療法の人気の高まり、セルフケアや自宅での治療に対する嗜好の高まりなどがあります。

インフルエンザの流行増加は、急性咽頭炎市場の成長を牽引すると予想されます。インフルエンザは、インフルエンザウイルスへの感染によって引き起こされ、咳やくしゃみ、汚染された表面との接触による呼吸器飛沫を介して感染します。季節の変化、ワクチン接種率の低下、人の移動の増加、ウイルスの突然変異、特定の集団における免疫力の低下などの要因が、インフルエンザ患者の増加に寄与しています。急性咽頭炎治療は、インフルエンザ患者の喉の炎症や痛みを和らげ、嚥下時の不快感を軽減し、二次的な細菌感染を予防し、全体的な回復をサポートします。抗ウイルス薬、適切な水分補給、休養と組み合わせることで、これらの治療はインフルエンザウイルスと闘う身体の能力を高めます。例えば、2月2025年現在、米国疾病予防管理センター（CDC）の報告によると、インフルエンザの臨床検査では31.6％が陽性であり、前週の29.4％、年初の18.6％から増加しています。このようなインフルエンザ患者の増加が、急性咽頭炎市場の成長に寄与しています。

急性咽頭炎市場の企業は、細菌感染をより効果的に治療し、抗生物質耐性を低減するための抗生物質の開発に注力しています。抗生物質は、化膿連鎖球菌などの細菌感染によって引き起こされる急性咽頭炎の治療に不可欠であり、細菌を除去し、症状を軽減し、リウマチ熱などの合併症を予防します。例えば、2022年2月、インドのAlembic Pharmaceuticals Limitedは、250mgと500mgのクラリスロマイシン錠剤について、米国食品医薬品局（FDA）から簡略新薬承認申請（ANDA）を取得しました。このマクロライド系抗生物質は、咽頭炎、扁桃炎、市中肺炎、慢性気管支炎などの軽度から中等度の細菌感染症の治療に使用されます。今回の承認は、急性咽頭炎およびその他の関連する細菌感染症の管理において、効果的な抗菌薬治療が重要であることを強調するものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界急性咽頭炎PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の急性咽頭炎市場：成長率分析
• 世界の急性咽頭炎市場の実績：規模と成長, 2019-2024
• 世界の急性咽頭炎市場の予測：規模と成長, 2024-2029, 2034F
• 世界急性咽頭炎総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の急性咽頭炎市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗生物質
• 抗ウイルス薬
• 市販薬（OTC）
• コルチコステロイドと抗炎症薬
• 代替療法
• 世界の急性咽頭炎市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• オンライン薬局
• 小売薬局
• 世界の急性咽頭炎市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• ホームケア
• 専門センター
• その他のエンドユーザー
• 世界の急性咽頭炎市場抗生物質の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ペニシリン
• セファロスポリン
• マクロライド
• 世界の急性咽頭炎市場抗ウイルス薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ノイラミニダーゼ阻害剤
• ヌクレオシド類似体
• 世界の急性咽頭炎市場市販薬（OTC）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 鎮痛剤
• のど飴
• 咳止めシロップ
• 世界の急性咽頭炎市場、コルチコステロイドおよび抗炎症薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• グルココルチコイド
• 非ステロイド性抗炎症薬（NSAID）
• 世界の急性咽頭炎市場代替療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハーブティー
• 蜂蜜ベースのソリューション
• 塩水うがい

第7章 地域別・国別分析

• 世界の急性咽頭炎市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の急性咽頭炎市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 急性咽頭炎市場：競合情勢
• 急性咽頭炎市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bristol-Myers Squibb
• AstraZeneca plc
• Novartis AG
• Glaxo Smithkline Pharmaceuticals Ltd
• F. Hoffmann-La Roche AG
• Eli Lilly and Company
• Amgen Inc.
• Boehringer Ingelheim
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Sandoz Group AG
• Bitop AG
• Hikma Pharmaceuticals
• Lupin Limited
• Alkem Laboratories Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 急性咽頭炎市場2029：新たな機会を提供する国
• 急性咽頭炎市場2029：新たな機会を提供するセグメント
• 急性咽頭炎市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Acute pharyngitis is the inflammation of the pharynx, a part of the throat located behind the mouth and nasal cavity, commonly causing a sore throat along with symptoms such as fever, headache, and swollen lymph nodes. This condition is most often caused by viral infections, though bacterial and fungal infections can also be responsible.

The primary treatments for acute pharyngitis include antibiotics, antivirals, over-the-counter (OTC) medications, corticosteroids, anti-inflammatory drugs, and alternative remedies. Antibiotics are used to treat bacterial infections by killing bacteria or inhibiting their growth. These treatments are distributed through various channels such as hospital pharmacies, online pharmacies, and retail pharmacies, with key end-users including hospitals, homecare settings, specialty centers, and other healthcare providers.

The acute pharyngitis market research report is one of a series of new reports from The Business Research Company that provides acute pharyngitis market statistics, including acute pharyngitis industry global market size, regional shares, competitors with an acute pharyngitis market share, detailed acute pharyngitis market segments, market trends and opportunities, and any further data you may need to thrive in the acute pharyngitis industry. This acute pharyngitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acute pharyngitis market size has grown strongly in recent years. It will grow from $2.67 billion in 2024 to $2.90 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to several factors, including the rising incidence of viral and bacterial infections, which have contributed to the increased demand for treatments. Additionally, growing healthcare awareness has led to earlier diagnosis and better management of acute pharyngitis. Advancements in diagnostic technologies have made it easier to identify the cause of infections, while the rising number of pediatric cases has further driven the market. Moreover, an increase in environmental pollutants and allergens has contributed to a higher prevalence of throat-related conditions.

The acute pharyngitis market size is expected to see rapid growth in the next few years. It will grow to $3.98 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The projected growth during the forecast period can be linked to factors such as the increasing prevalence of influenza and streptococcal infections, a stronger emphasis on personalized medicine, higher adoption rates of rapid diagnostic tests, advancements in healthcare infrastructure, and broader healthcare access in emerging markets. Key trends expected to shape the forecast period include a shift toward over-the-counter treatments, a rise in the use of combination therapies, the expansion of telemedicine for diagnosing pharyngitis, growing popularity of natural and alternative remedies, and an increasing preference for self-care and home treatments.

The increasing prevalence of influenza is expected to drive the growth of the acute pharyngitis market. Influenza is caused by infection with influenza viruses, which spread through respiratory droplets from coughs, sneezes, or contact with contaminated surfaces. Factors such as seasonal changes, low vaccination rates, increased human mobility, viral mutations, and weakened immunity in certain populations contribute to the rise in influenza cases. Acute pharyngitis treatment helps alleviate throat inflammation and pain in influenza patients, reducing discomfort while swallowing, preventing secondary bacterial infections, and supporting overall recovery. When combined with antiviral medications, proper hydration, and rest, these treatments enhance the body's ability to combat the influenza virus. For example, as of February 2025, the Centers for Disease Control and Prevention (CDC) reported that 31.6% of clinical lab tests for influenza were positive, up from 29.4% the previous week and 18.6% at the start of the year. This increase in influenza cases is contributing to the growth of the acute pharyngitis market.

Companies in the acute pharyngitis market are focusing on developing antibiotics to treat bacterial infections more effectively and reduce antibiotic resistance. Antibiotics are essential for treating acute pharyngitis caused by bacterial infections, such as streptococcus pyogenes, by eliminating the bacteria, reducing symptoms, and preventing complications such as rheumatic fever. For example, in February 2022, Alembic Pharmaceuticals Limited, an India-based company, received Abbreviated New Drug Application (ANDA) approval from the US Food and Drug Administration (FDA) for Clarithromycin tablets, available in 250 mg and 500 mg dosages. This macrolide antibiotic is used to treat mild to moderate bacterial infections, including pharyngitis, tonsillitis, community-acquired pneumonia, and chronic bronchitis. The approval highlights the importance of effective antimicrobial treatments in managing acute pharyngitis and other related bacterial infections.

In November 2022, TPG Inc., a US-based private equity firm, acquired a majority stake in iNova Pharmaceuticals for $1.3 billion. With this acquisition, TPG Inc. aims to accelerate growth, expand market reach, and enhance its product offerings in the healthcare sector, particularly in Southeast and North Asia. iNova Pharmaceuticals, based in Singapore, focuses on providing over-the-counter products designed to relieve pharyngitis symptoms, such as throat lozenges and pain relievers.

Major players in the acute pharyngitis market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Merck & Co. Inc., Sanofi S.A., Bristol-Myers Squibb, AstraZeneca plc, Novartis AG, Glaxo Smithkline Pharmaceuticals Ltd, F. Hoffmann-La Roche AG, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz Group AG, Bitop AG, Hikma Pharmaceuticals, Lupin Limited, Alkem Laboratories Ltd., MEDICE Arzneimittel Putter GmbH & Co. KG, MCM Klosterfrau Vertriebsgesellschaft mbH.

North America was the largest region in the acute pharyngitis market in 2024. The regions covered in acute pharyngitis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the Acute Pharyngitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The acute pharyngitis market consists of revenues earned by entities by providing services such as diagnostic testing services, pharmaceutical dispensing services, and preventive and vaccination services. The market value includes the value of related goods sold by the service provider or included within the service offering. The acute pharyngitis market also includes sales of penicillin, amoxicillin, azithromycin, throat gargles and rinses. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acute Pharyngitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acute pharyngitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acute pharyngitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acute pharyngitis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Antibiotics; Antivirals; Over-the-Counter (OTC) Medications; Corticosteroids And Anti-inflammatory Drugs; Alternative Remedies
• 2) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• 3) By End-User: Hospitals; Homecare; Speciality Centres; Other End Users
• Subsegments:
• 1) By Antibiotics: Penicillins; Cephalosporins; Macrolides
• 2) By Antivirals: Neuraminidase Inhibitors; Nucleoside Analogs
• 3) By Over-the-Counter (OTC) Medications: Analgesics; Throat Lozenges; Cough Syrups
• 4) By Corticosteroids And Anti-inflammatory Drugs: Glucocorticoids; Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• 5) By Alternative Remedies: Herbal Teas; Honey-Based Solutions; Saltwater Gargles
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Merck & Co. Inc.; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Acute Pharyngitis Market Characteristics

3. Acute Pharyngitis Market Trends And Strategies

4. Acute Pharyngitis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Acute Pharyngitis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Acute Pharyngitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Acute Pharyngitis Market Growth Rate Analysis
• 5.4. Global Acute Pharyngitis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Acute Pharyngitis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Acute Pharyngitis Total Addressable Market (TAM)

6. Acute Pharyngitis Market Segmentation

• 6.1. Global Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Antivirals
• Over-the-Counter (OTC) Medications
• Corticosteroids And Anti-inflammatory Drugs
• Alternative Remedies
• 6.2. Global Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.3. Global Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Speciality Centres
• Other End Users
• 6.4. Global Acute Pharyngitis Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Penicillins
• Cephalosporins
• Macrolides
• 6.5. Global Acute Pharyngitis Market, Sub-Segmentation Of Antivirals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neuraminidase Inhibitors
• Nucleoside Analogs
• 6.6. Global Acute Pharyngitis Market, Sub-Segmentation Of Over-the-Counter (OTC) Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Analgesics
• Throat Lozenges
• Cough Syrups
• 6.7. Global Acute Pharyngitis Market, Sub-Segmentation Of Corticosteroids And Anti-inflammatory Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glucocorticoids
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• 6.8. Global Acute Pharyngitis Market, Sub-Segmentation Of Alternative Remedies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Herbal Teas
• Honey-Based Solutions
• Saltwater Gargles

7. Acute Pharyngitis Market Regional And Country Analysis

• 7.1. Global Acute Pharyngitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Acute Pharyngitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Acute Pharyngitis Market

• 8.1. Asia-Pacific Acute Pharyngitis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Acute Pharyngitis Market

• 9.1. China Acute Pharyngitis Market Overview
• 9.2. China Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Acute Pharyngitis Market

• 10.1. India Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Acute Pharyngitis Market

• 11.1. Japan Acute Pharyngitis Market Overview
• 11.2. Japan Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Acute Pharyngitis Market

• 12.1. Australia Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Acute Pharyngitis Market

• 13.1. Indonesia Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Acute Pharyngitis Market

• 14.1. South Korea Acute Pharyngitis Market Overview
• 14.2. South Korea Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Acute Pharyngitis Market

• 15.1. Western Europe Acute Pharyngitis Market Overview
• 15.2. Western Europe Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Acute Pharyngitis Market

• 16.1. UK Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Acute Pharyngitis Market

• 17.1. Germany Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Acute Pharyngitis Market

• 18.1. France Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Acute Pharyngitis Market

• 19.1. Italy Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Acute Pharyngitis Market

• 20.1. Spain Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Acute Pharyngitis Market

• 21.1. Eastern Europe Acute Pharyngitis Market Overview
• 21.2. Eastern Europe Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Acute Pharyngitis Market

• 22.1. Russia Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Acute Pharyngitis Market

• 23.1. North America Acute Pharyngitis Market Overview
• 23.2. North America Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Acute Pharyngitis Market

• 24.1. USA Acute Pharyngitis Market Overview
• 24.2. USA Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Acute Pharyngitis Market

• 25.1. Canada Acute Pharyngitis Market Overview
• 25.2. Canada Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Acute Pharyngitis Market

• 26.1. South America Acute Pharyngitis Market Overview
• 26.2. South America Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Acute Pharyngitis Market

• 27.1. Brazil Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Acute Pharyngitis Market

• 28.1. Middle East Acute Pharyngitis Market Overview
• 28.2. Middle East Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Acute Pharyngitis Market

• 29.1. Africa Acute Pharyngitis Market Overview
• 29.2. Africa Acute Pharyngitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Acute Pharyngitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Acute Pharyngitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Acute Pharyngitis Market Competitive Landscape And Company Profiles

• 30.1. Acute Pharyngitis Market Competitive Landscape
• 30.2. Acute Pharyngitis Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Acute Pharyngitis Market Other Major And Innovative Companies

• 31.1. Bristol-Myers Squibb
• 31.2. AstraZeneca plc
• 31.3. Novartis AG
• 31.4. Glaxo Smithkline Pharmaceuticals Ltd
• 31.5. F. Hoffmann-La Roche AG
• 31.6. Eli Lilly and Company
• 31.7. Amgen Inc.
• 31.8. Boehringer Ingelheim
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. Mylan N.V.
• 31.11. Sandoz Group AG
• 31.12. Bitop AG
• 31.13. Hikma Pharmaceuticals
• 31.14. Lupin Limited
• 31.15. Alkem Laboratories Ltd.

32. Global Acute Pharyngitis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Acute Pharyngitis Market

34. Recent Developments In The Acute Pharyngitis Market

35. Acute Pharyngitis Market High Potential Countries, Segments and Strategies

• 35.1 Acute Pharyngitis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Acute Pharyngitis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Acute Pharyngitis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer